Cas no 1070879-38-7 (4-bromo-5,8-dichloroquinoline)
4-bromo-5,8-dichloroquinoline Chemical and Physical Properties
Names and Identifiers
-
- 4-bromo-5,8-dichloroquinoline
- CTK4A4967
- AG-D-21964
- KB-240754
- CS-0366772
- DTXSID10653687
- VSB87938
- 1070879-38-7
- DB-059551
- MFCD11505120
-
- Inchi: 1S/C9H4BrCl2N/c10-5-3-4-13-9-7(12)2-1-6(11)8(5)9/h1-4H
- InChI Key: IUDIYVBYMWRXDM-UHFFFAOYSA-N
- SMILES: BrC1C=CN=C2C(=CC=C(C2=1)Cl)Cl
Computed Properties
- Exact Mass: 274.89000
- Monoisotopic Mass: 274.89042g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 13
- Rotatable Bond Count: 0
- Complexity: 191
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.1
- Topological Polar Surface Area: 12.9?2
Experimental Properties
- PSA: 12.89000
- LogP: 4.30410
4-bromo-5,8-dichloroquinoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B998755-50mg |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 50mg |
$ 70.00 | 2022-06-01 | ||
| TRC | B998755-100mg |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 100mg |
$ 95.00 | 2022-06-01 | ||
| TRC | B998755-500mg |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 500mg |
$ 365.00 | 2022-06-01 | ||
| Apollo Scientific | OR309287-1g |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 1g |
£343.00 | 2025-02-20 | ||
| abcr | AB292350-250 mg |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 250MG |
€239.50 | 2022-06-11 | ||
| abcr | AB292350-1 g |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 1g |
€516.00 | 2022-06-11 | ||
| abcr | AB292350-5 g |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 5g |
€1,306.00 | 2022-06-11 | ||
| 1PlusChem | 1P007BN0-250mg |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 95% | 250mg |
$163.00 | 2025-02-22 | |
| 1PlusChem | 1P007BN0-500mg |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 95% | 500mg |
$242.00 | 2025-02-22 | |
| 1PlusChem | 1P007BN0-1g |
4-Bromo-5,8-dichloroquinoline |
1070879-38-7 | 95% | 1g |
$361.00 | 2025-02-22 |
4-bromo-5,8-dichloroquinoline Related Literature
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
Additional information on 4-bromo-5,8-dichloroquinoline
Comprehensive Overview of 4-Bromo-5,8-Dichloroquinoline (CAS No. 1070879-38-7): Properties, Applications, and Research Insights
The compound 4-bromo-5,8-dichloroquinoline (CAS No. 1070879-38-7) is a halogenated quinoline derivative that has garnered significant attention in pharmaceutical and materials science research. With its unique molecular structure featuring bromine and chlorine substituents, this compound serves as a versatile intermediate in organic synthesis. Its CAS number 1070879-38-7 is frequently searched in chemical databases, reflecting its relevance in modern drug discovery and agrochemical development.
Recent trends highlight growing interest in quinoline-based compounds due to their broad biological activities, including antimicrobial and anticancer properties. Researchers are actively exploring 4-bromo-5,8-dichloroquinoline as a building block for novel therapeutics, particularly in targeting resistant pathogens—a hot topic in post-pandemic research. The compound's halogenated structure also makes it valuable for designing advanced materials, such as organic semiconductors and luminescent probes.
From a synthetic chemistry perspective, the bromine and dichloro functional groups in CAS 1070879-38-7 enable diverse cross-coupling reactions, including Suzuki-Miyaura and Buchwald-Hartwig transformations. This aligns with the current focus on sustainable catalysis, as evidenced by frequent searches for "green synthesis of halogenated quinolines." The compound's crystalline properties and stability under various conditions further enhance its utility in high-throughput screening platforms.
Analytical characterization of 4-bromo-5,8-dichloroquinoline typically involves advanced techniques like NMR (1H/13C), LC-MS, and X-ray crystallography—methods commonly queried alongside this CAS number. Recent publications emphasize its role in developing PET radiotracers for neurological imaging, connecting it to trending topics in precision medicine. Regulatory databases show increasing patent filings involving this scaffold, particularly in kinase inhibitor formulations.
Environmental and safety studies of halogenated quinoline derivatives remain an active area of investigation, with researchers optimizing degradation pathways. This addresses the frequently asked question: "Are halogenated quinolines biodegradable?" The electron-withdrawing nature of its substituents makes 1070879-38-7 particularly interesting for photophysical studies, correlating with rising searches for "fluorescence properties of chlorinated quinolines."
In material science applications, the planar structure of 4-bromo-5,8-dichloroquinoline facilitates π-stacking interactions, making it valuable for organic electronic devices. This connects to the booming interest in flexible electronics, as seen in search trends for "quinoline-based OLED materials." Computational chemistry studies utilizing DFT calculations frequently reference this compound when modeling charge transport properties.
The global market for quinoline intermediates shows steady growth, with CAS 1070879-38-7 appearing in supplier catalogs as a high-purity reference standard. Quality control protocols often specify HPLC purity ≥98%, reflecting industry standards for research-grade chemicals. Storage recommendations typically suggest inert atmosphere protection due to the compound's sensitivity to prolonged light exposure.
Emerging applications include the use of brominated quinolines in covalent organic frameworks (COFs), a trending topic in nanotechnology forums. The compound's ability to participate in Sonogashira couplings makes it valuable for constructing porous materials—addressing frequent queries about "functionalized quinoline linkers." Recent conferences have highlighted its potential in designing selective chemosensors for environmental monitoring.
Academic courses on heterocyclic chemistry increasingly feature 4-bromo-5,8-dichloroquinoline as a case study for electrophilic substitution patterns, coinciding with student searches for "quinoline reaction mechanisms." The compound's distinct 1H-NMR splitting patterns serve as excellent teaching examples for advanced spectroscopy classes. Synthetic protocols often emphasize its regioselective functionalization at the 6-position.
Future research directions may explore the compound's role in fragment-based drug discovery, particularly for protein-protein interaction inhibition—a hot topic in pharmaceutical searches. The presence of both bromine and chlorine atoms allows sequential modification strategies, enabling structure-activity relationship studies. Current literature suggests untapped potential in asymmetric catalysis when using this scaffold as a chiral ligand precursor.
1070879-38-7 (4-bromo-5,8-dichloroquinoline) Related Products
- 1070879-40-1(4-bromo-7,8-dichloroquinoline)
- 126811-30-1(4-Bromo-7-chloro-1H-indole)
- 1246549-62-1(7-bromo-3-chloro-quinoline)
- 1215770-74-3(5-bromo-3-chloro-quinoline)
- 35478-81-0(4-bromo-6,8-dichloroquinoline)
- 927800-41-7(5-Bromo-8-chloroquinoline)
- 16567-13-8(6-Bromo-8-chloroquinoline)
- 203261-25-0(4-bromo-5,7-dichloroquinoline)
- 57916-08-2(6-bromo-3-chloro-1h-indole)
- 927800-40-6(4-Bromo-8-chloroquinoline)